CARDIOGENESIS CORPORATION
Table of Contents



SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): December 31, 2002

CardioGenesis Corporation


(Exact Name of Registrant as Specified in Charter)
         
California   000-28288   77-0223740

 
 
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)
         
26632 Towne Centre Drive, Suite 320,
Foothill Ranch, California
     
92610

     
(Address of Principal Executive Offices)       (Zip Code)

Registrant’s telephone number, including area code: (714) 649-5000


(Former Name or Former Address, if Changed Since Last Report)



 


TABLE OF CONTENTS

Item 5. Other Events
Item 7. Financial Information, Pro Forma Financial Information and Exhibits
SIGNATURE
EXHIBIT INDEX
EXHIBIT 99.1


Table of Contents

Item 5. Other Events

     On December 31, 2002, the Registrant issued a press release titled “CardioGenesis Corporation to Appeal Nasdaq Delisting Notice,” a copy of which is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 7. Financial Information, Pro Forma Financial Information and Exhibits

     (a)  Not applicable.

     (b)  Not applicable.

     (c)  Exhibits:

     Pursuant to General Instruction F of Form 8-K, the following documents are incorporated by reference herein and attached as exhibits hereto:

     
Exhibit   Description

 
99.1   Press release of CardioGenesis Corporation dated December 31, 2002, titled “CardioGenesis Corporation to Appeal Nasdaq Delisting Notice.”

 


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this current report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    CARDIOGENESIS CORPORATION
         
Date: January 3, 2003   By:   /s/ DARRELL F. ECKSTEIN
       
        Darrell F. Eckstein
President, Chief Operating Officer
and Acting Chief Financial Officer

 


Table of Contents

EXHIBIT INDEX

     
Exhibit   Description

 
99.1   Press release of CardioGenesis Corporation dated December 31, 2002, titled “CardioGenesis Corporation to Appeal Nasdaq Delisting Notice.”